Decision

Janssen Inc. v. Pfizer Canada Inc., 2019 FCA 188 (Infliximab*)

Justice Gleason; Justice Boivin; Justice Rennie - 2019-06-20

Read full decision. Automatically generated summary:

The appellants appeal from the portions of the order of the Federal Court (per Southcott J.) in Hospira Healthcare Corporation v. Kennedy Institute of Rheumatology, 2018 FC 992, in which the Federal Court dismissed the appellants’ motion under Rule 233 of the Federal Courts Rules, SOR/98-106 for an order requiring production of documents from a non-party.

Decision relates to:

 

Canadian Intellectual Property